Elstein K H, Mole M L, Setzer R W, Zucker R M, Kavlock R J, Rogers J M, Lau C
National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA.
Toxicol Appl Pharmacol. 1997 Sep;146(1):29-39. doi: 10.1006/taap.1997.8208.
5-Fluorouracil (5-FU) is a chemotherapeutic agent known to retard embryonic growth and induce cleft palate and limb deformities. The predominant mechanism underlying its toxic action is thought to be inhibition of thymidylate synthetase (TS), and hence thymidine triphosphate (dTTP) synthesis, resulting in alteration of the balance of deoxynucleotide (dNTP) pools and disruption of DNA synthesis. Indeed, previously we demonstrated retarded cell-cycle progression concurrent with a 60% decrease in TS activity in rat whole embryos following maternal exposure to 40 mg/kg 5-FU on Gestational Day 14 and in the murine erythroleukemic cell (MELC) suspension culture following exposure to 5-25 microM 5-FU for 2 hr. In the study described herein, we used high-performance liquid chromatography (HPLC) to demonstrate in both of these model systems that 5-FU exposure results in similar patterns of dNTP perturbations: a prolonged decrease in dTTP and dGTP levels and an increase in dCTP and dATP. In addition, we used centrifugal elutriation to synchronize MELC in the phases of the cell cycle (G0/G1 and early S) most sensitive to 5-FU to investigate the ability of nucleoside supplementation to mitigate 5-FU-induced toxicity. Our data indicate that following a 2-hr exposure to 5-25 microM 5-FU, supplementation with 1-10 microM thymidine (TdR) for 24 hr partially reverses 5-FU-induced toxicity as evidenced by increased cellular proliferation and cell-cycle progression and amelioration of 5-FU-induced perturbations of protein synthesis and cellular membrane permeability compared to unsupplemented 5-FU-exposed cells. However, TdR concentrations >/=100 microM inhibited growth or were cytotoxic. In comparison, supplementation with 10 microM-10 mM of deoxycytidine (CdR) was not toxic, but effected a dose-dependent recovery from 5-FU-induced toxicity. At 1-100 microM, neither deoxyadenosine nor deoxyguanosine supplementation reduced 5-FU-induced toxicity; at higher concentrations, both purine nucleotides inhibited cell growth. Although these results support the hypothesis that 5-FU disrupts the MELC cell cycle by depleting dTTP (a perturbation that is reversible by TdR supplementation), they also indicate that CdR supplementation offers an additional recovery pathway.
5-氟尿嘧啶(5-FU)是一种化疗药物,已知其会阻碍胚胎生长并诱发腭裂和肢体畸形。其毒性作用的主要机制被认为是抑制胸苷酸合成酶(TS),从而抑制三磷酸胸苷(dTTP)的合成,导致脱氧核苷酸(dNTP)池平衡改变以及DNA合成中断。实际上,此前我们证明,在妊娠第14天母体暴露于40mg/kg 5-FU后,大鼠全胚胎的细胞周期进程延迟,同时TS活性降低60%;在暴露于5-25μM 5-FU 2小时后的小鼠红白血病细胞(MELC)悬浮培养物中也观察到类似情况。在本文所述的研究中,我们使用高效液相色谱法(HPLC)在这两种模型系统中均证明,5-FU暴露会导致类似的dNTP扰动模式:dTTP和dGTP水平持续下降,dCTP和dATP增加。此外,我们使用离心淘析法将MELC同步到细胞周期中对5-FU最敏感的阶段(G0/G1和早期S期),以研究核苷补充减轻5-FU诱导毒性 的能力。我们的数据表明,在暴露于5-25μM 5-FU 2小时后,补充1-10μM胸苷(TdR)24小时可部分逆转5-FU诱导的毒性,这表现为细胞增殖和细胞周期进程增加,与未补充TdR的5-FU暴露细胞相比,5-FU诱导的蛋白质合成和细胞膜通透性扰动得到改善。然而,TdR浓度≥100μM会抑制生长或具有细胞毒性。相比之下,补充10μM-10mM脱氧胞苷(CdR)无毒,但能剂量依赖性地从5-FU诱导的毒性中恢复。在1-100μM时,补充脱氧腺苷或脱氧鸟苷均不能降低5-FU诱导的毒性;在更高浓度下,这两种嘌呤核苷酸均会抑制细胞生长。尽管这些结果支持了5-FU通过消耗dTTP破坏MELC细胞周期的假说(这种扰动可通过补充TdR逆转),但它们也表明补充CdR提供了另一条恢复途径。